Product categories

You can contact us any way that is convenient for you. We are available 24/7 via email or telephone.

New Products

${"id":1,"admin_user_id":1,"product_brand_id":null,"sort":0,"url_key":"product-01","active":1,"is_new":1,"is_hot":1,"is_recommend":1,"add_date":202404,"attribute_category_id":1,"created_at":"2024-04-22 16:22:26","updated_at":"2024-04-29 16:36:31","video":null,"is_translate":0,"category_name":"Multifunctional Axe","art_no":null,"name":"product 01","brief_content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc.<\/p>","content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>\nThe group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>","content_1":null,"content_2":null,"content_3":null,"content_4":null,"content_5":null,"content_6":null,"content_7":null,"content_8":null,"content_9":null,"content_10":null,"m_content":null,"attribute":null,"title":null,"keywords":null,"description":null,"translations":[{"id":1,"product_id":1,"locale":"en","name":"product 01","brief_content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc.<\/p>","content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>\nThe group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>","m_content":null,"attribute":null,"title":null,"keywords":null,"description":null}],"product_images":[{"id":36,"product_id":1,"path":"storage\/uploads\/images\/202404\/22\/1713774123_ozxpxPTOMa.jpg","is_main":1,"alt":"","sort":0,"created_at":"2024-04-24T02:55:38.000000Z","updated_at":"2024-04-24T02:55:38.000000Z"}],"url":{"id":54,"url":"product-01","urlable_type":"App\\Modules\\Product\\Models\\Product","urlable_id":1,"created_at":"2024-04-29T08:36:31.000000Z","updated_at":"2024-04-29T08:36:31.000000Z","deleted_at":null}}$
product 01
Read More
${"id":2,"admin_user_id":1,"product_brand_id":null,"sort":0,"url_key":"product-02","active":1,"is_new":1,"is_hot":1,"is_recommend":1,"add_date":202404,"attribute_category_id":1,"created_at":"2024-04-22 16:22:45","updated_at":"2024-04-29 16:36:31","video":null,"is_translate":0,"category_name":"Damascus knife","art_no":null,"name":"product 02","brief_content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc.<\/p>","content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>\nThe group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>","content_1":null,"content_2":null,"content_3":null,"content_4":null,"content_5":null,"content_6":null,"content_7":null,"content_8":null,"content_9":null,"content_10":null,"m_content":null,"attribute":null,"title":null,"keywords":null,"description":null,"translations":[{"id":2,"product_id":2,"locale":"en","name":"product 02","brief_content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc.<\/p>","content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>\nThe group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>","m_content":null,"attribute":null,"title":null,"keywords":null,"description":null}],"product_images":[{"id":42,"product_id":2,"path":"storage\/uploads\/images\/202404\/22\/1713774123_3SEelxI1Zx.jpg","is_main":1,"alt":"","sort":0,"created_at":"2024-04-24T02:56:20.000000Z","updated_at":"2024-04-24T02:56:20.000000Z"}],"url":{"id":55,"url":"product-02","urlable_type":"App\\Modules\\Product\\Models\\Product","urlable_id":2,"created_at":"2024-04-29T08:36:31.000000Z","updated_at":"2024-04-29T08:36:31.000000Z","deleted_at":null}}$
product 02
Read More
${"id":3,"admin_user_id":1,"product_brand_id":null,"sort":0,"url_key":"product-03","active":1,"is_new":1,"is_hot":1,"is_recommend":1,"add_date":202404,"attribute_category_id":0,"created_at":"2024-04-22 16:23:04","updated_at":"2024-04-29 16:36:31","video":null,"is_translate":0,"category_name":"Wood handle knife","art_no":null,"name":"product 03","brief_content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc.<\/p>","content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>\nThe group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>","content_1":null,"content_2":null,"content_3":null,"content_4":null,"content_5":null,"content_6":null,"content_7":null,"content_8":null,"content_9":null,"content_10":null,"m_content":null,"attribute":null,"title":null,"keywords":null,"description":null,"translations":[{"id":3,"product_id":3,"locale":"en","name":"product 03","brief_content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc.<\/p>","content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>\nThe group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>","m_content":null,"attribute":null,"title":null,"keywords":null,"description":null}],"product_images":[{"id":13,"product_id":3,"path":"storage\/uploads\/images\/202404\/22\/1713774123_eoDG9ympY0.jpg","is_main":1,"alt":"","sort":0,"created_at":"2024-04-22T08:23:04.000000Z","updated_at":"2024-04-22T08:23:04.000000Z"}],"url":{"id":56,"url":"product-03","urlable_type":"App\\Modules\\Product\\Models\\Product","urlable_id":3,"created_at":"2024-04-29T08:36:31.000000Z","updated_at":"2024-04-29T08:36:31.000000Z","deleted_at":null}}$
product 03
Read More
${"id":4,"admin_user_id":1,"product_brand_id":null,"sort":0,"url_key":"product-04","active":1,"is_new":1,"is_hot":1,"is_recommend":1,"add_date":202404,"attribute_category_id":0,"created_at":"2024-04-22 16:23:31","updated_at":"2024-04-29 16:36:31","video":null,"is_translate":0,"category_name":"Damascus knife","art_no":null,"name":"product 04","brief_content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc.<\/p>","content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>\nThe group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>","content_1":null,"content_2":null,"content_3":null,"content_4":null,"content_5":null,"content_6":null,"content_7":null,"content_8":null,"content_9":null,"content_10":null,"m_content":null,"attribute":null,"title":null,"keywords":null,"description":null,"translations":[{"id":4,"product_id":4,"locale":"en","name":"product 04","brief_content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc.<\/p>","content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>\nThe group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>","m_content":null,"attribute":null,"title":null,"keywords":null,"description":null}],"product_images":[{"id":19,"product_id":4,"path":"storage\/uploads\/images\/202404\/22\/1713774123_8Zi0ZZ5JM8.jpg","is_main":1,"alt":"","sort":0,"created_at":"2024-04-22T08:23:31.000000Z","updated_at":"2024-04-22T08:23:31.000000Z"}],"url":{"id":57,"url":"product-04","urlable_type":"App\\Modules\\Product\\Models\\Product","urlable_id":4,"created_at":"2024-04-29T08:36:31.000000Z","updated_at":"2024-04-29T08:36:31.000000Z","deleted_at":null}}$
product 04
Read More
${"id":5,"admin_user_id":1,"product_brand_id":null,"sort":0,"url_key":"product-05","active":1,"is_new":1,"is_hot":1,"is_recommend":1,"add_date":202404,"attribute_category_id":0,"created_at":"2024-04-22 16:23:43","updated_at":"2025-07-04 16:13:57","video":"https:\/\/play.video.alibaba.com\/global\/play\/450513403699.mp4?dft=hd","is_translate":0,"category_name":"G10 handle knife","art_no":null,"name":"product 05","brief_content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc.<\/p>","content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>\nThe group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>","content_1":null,"content_2":null,"content_3":null,"content_4":null,"content_5":null,"content_6":null,"content_7":null,"content_8":null,"content_9":null,"content_10":null,"m_content":null,"attribute":null,"title":null,"keywords":null,"description":null,"translations":[{"id":5,"product_id":5,"locale":"en","name":"product 05","brief_content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc.<\/p>","content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>\nThe group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>","m_content":null,"attribute":null,"title":null,"keywords":null,"description":null}],"product_images":[{"id":607,"product_id":5,"path":"storage\/uploads\/images\/202404\/22\/1713774123_rPsh7l4OJz.jpg","is_main":1,"alt":"","sort":0,"created_at":"2025-07-04T08:13:57.000000Z","updated_at":"2025-07-04T08:13:57.000000Z"}],"url":{"id":58,"url":"product-05","urlable_type":"App\\Modules\\Product\\Models\\Product","urlable_id":5,"created_at":"2024-04-29T08:36:31.000000Z","updated_at":"2025-07-04T08:13:57.000000Z","deleted_at":null}}$
product 05
Read More
8.46-inch space aluminum handle with multiple colors butterfly knife
Read More
${"id":7,"admin_user_id":1,"product_brand_id":null,"sort":0,"url_key":"product-07","active":1,"is_new":1,"is_hot":1,"is_recommend":1,"add_date":202404,"attribute_category_id":0,"created_at":"2024-04-22 16:24:34","updated_at":"2025-07-04 16:11:29","video":"https:\/\/play.video.alibaba.com\/global\/play\/468286880460.mp4?dft=sd","is_translate":0,"category_name":"Wood handle knife","art_no":null,"name":"product 07","brief_content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc.<\/p>","content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>\nThe group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>","content_1":null,"content_2":null,"content_3":null,"content_4":null,"content_5":null,"content_6":null,"content_7":null,"content_8":null,"content_9":null,"content_10":null,"m_content":null,"attribute":null,"title":null,"keywords":null,"description":null,"translations":[{"id":7,"product_id":7,"locale":"en","name":"product 07","brief_content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc.<\/p>","content":"The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>\nThe group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation. We have the most advanced automated production lines, a professional team, and a flexible strategic management system. We will provide the most professional products and the most sincere services to customers around the world. We will continue to adopt a globalization strategy, improve service quality, expand brand reputation, and become a competitive international enterprise.<\/p>","m_content":null,"attribute":null,"title":null,"keywords":null,"description":null}],"product_images":[{"id":600,"product_id":7,"path":"storage\/uploads\/images\/202404\/22\/1713774123_eoDG9ympY0.jpg","is_main":1,"alt":"","sort":0,"created_at":"2025-07-04T08:11:29.000000Z","updated_at":"2025-07-04T08:11:29.000000Z"}],"url":{"id":60,"url":"product-07","urlable_type":"App\\Modules\\Product\\Models\\Product","urlable_id":7,"created_at":"2024-04-29T08:36:31.000000Z","updated_at":"2025-07-04T08:11:29.000000Z","deleted_at":null}}$
product 07
Read More
Multi-function Camping Shovels
Read More

Product Name:	Butterfly Training Tool
Overall Length:	215MM
Blade Length:	98MM
Material：	7075 Aluminum Alloy
weight：	108g
Logo:	Custom logo (laser, etching, stamping)
Packing:	Black box
Handle technology：	Anodized,integrated CNC handle
Surface	Anodized

8.46-inch space aluminum handle with multiple colors butterfly knife

Outdoor shovel & knife Tools

Multifunctional Axe

Multi functional pliers

Claw knife

Butterfly Knife

Fixed blade knife

OTF knife

Titanium alloy knife

Damascus knife

M390/D2 steel knife

G10 handle knife

Wood handle knife

Related Products